H Scheurlen

1.0k total citations
27 papers, 423 citations indexed

About

H Scheurlen is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, H Scheurlen has authored 27 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 5 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in H Scheurlen's work include Breast Cancer Treatment Studies (5 papers), Cardiac Valve Diseases and Treatments (4 papers) and Genetic factors in colorectal cancer (3 papers). H Scheurlen is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Cardiac Valve Diseases and Treatments (4 papers) and Genetic factors in colorectal cancer (3 papers). H Scheurlen collaborates with scholars based in Germany, United Kingdom and Switzerland. H Scheurlen's co-authors include Manfred Olschewski, Franz Schwarz, W. Kübler, H Zebe, G. Mall, J Manthey, Michael Baum, Richard Kay, Jack Cuzick and Michael Baum and has published in prestigious journals such as Circulation, Annals of Hematology and Pharmacopsychiatry.

In The Last Decade

H Scheurlen

24 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H Scheurlen Germany	8	186	76	69	67	66	27	423
L Holmberg Sweden	10	58 0.3×	73 1.0×	64 0.9×	157 2.3×	31 0.5×	12	383
Andrew Woolston United Kingdom	10	178 1.0×	65 0.9×	67 1.0×	135 2.0×	72 1.1×	19	523
Haseeb Jafri United States	6	98 0.5×	129 1.7×	185 2.7×	48 0.7×	16 0.2×	11	409
Eva Bjerre Ostenfeld Denmark	10	110 0.6×	56 0.7×	92 1.3×	144 2.1×	39 0.6×	20	353
Susan L. Rohland Canada	10	82 0.4×	22 0.3×	109 1.6×	84 1.3×	28 0.4×	16	367
William Odling-Smee United Kingdom	9	81 0.4×	34 0.4×	98 1.4×	111 1.7×	15 0.2×	23	350
John F. Lancaster United States	11	153 0.8×	42 0.6×	102 1.5×	131 2.0×	18 0.3×	25	469
A P Fletcher United States	5	71 0.4×	24 0.3×	48 0.7×	10 0.1×	32 0.5×	8	304
Anna‐Katharina Meinecke Germany	13	257 1.4×	19 0.3×	64 0.9×	45 0.7×	15 0.2×	19	494
Giulia Peveri Italy	12	71 0.4×	41 0.5×	67 1.0×	198 3.0×	14 0.2×	18	457

Countries citing papers authored by H Scheurlen

Since Specialization

Citations

This map shows the geographic impact of H Scheurlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Scheurlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Scheurlen more than expected).

Fields of papers citing papers by H Scheurlen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Scheurlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Scheurlen. The network helps show where H Scheurlen may publish in the future.

Co-authorship network of co-authors of H Scheurlen

This figure shows the co-authorship network connecting the top 25 collaborators of H Scheurlen. A scholar is included among the top collaborators of H Scheurlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Scheurlen. H Scheurlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Friedl, W., et al.. (2008). Der Wert der Strahlentherapie nach modifiziert radikaler Mastektomie: 10-Jahres-Ergebnisse der Heidelberger Studie. DMW - Deutsche Medizinische Wochenschrift. 108(9). 325–330. 2 indexed citations

Daniel, Volker, et al.. (1991). Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation. Annals of Hematology. 62(2-3). 68–73. 14 indexed citations

Scheurlen, H. (1989). Randomized Multicenter 2 × 2-Factorial Design Study of Chemo/Endocrine Therapy in Operable, Node-Positive Breast Cancer (Protocol 2). Recent results in cancer research. 115. 226–235. 1 indexed citations

Scheurlen, H, R. Kay, & Michael Baum. (1988). Cancer clinical trials : a critical appraisal. Springer eBooks. 7 indexed citations

Olschewski, Manfred, Rolf Verres, H Scheurlen, & H. Rauschecker. (1988). Evaluation of Psychosocial Aspects in a Breast Preservation Trial. Recent results in cancer research. 111. 258–269. 7 indexed citations

Cuzick, Jack, Helen Stewart, Richard Peto, et al.. (1987). Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer.. PubMed. 111(1). 108–29. 73 indexed citations

Schwarz, Florian, Manfred Olschewski, H Scheurlen, et al.. (1986). [Surgical indications in mitral valve stenosis, combined mitral valve defect or mitral valve insufficiency. Long-term prognosis of operated or drug-treated patients].. PubMed. 11(2). 74–87.

Schwarz, Franz, et al.. (1986). Patients with significant aortic incompetence should not be operated on until they are symptomatic.. PubMed. 75 Suppl 2. 133–6. 6 indexed citations

Schwarz, Florian, K Ruffmann, H Scheurlen, et al.. (1986). [Determinants of long-term prognosis following prosthetic mitral valve replacement].. PubMed. 75(11). 646–9. 2 indexed citations

10.

Olschewski, Manfred & H Scheurlen. (1985). Comprehensive Cohort Study: An Alternative to Randomized Consent Design in a Breast Preservation Trial. Methods of Information in Medicine. 24(3). 131–134. 55 indexed citations

11.

Schwarz, Franz, G. Mall, H Zebe, et al.. (1984). Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics.. Circulation. 70(6). 923–928. 127 indexed citations

12.

Scheurlen, H, et al.. (1982). On the use of hazard functions in breast cancer studies.. PubMed. 41. 118–30. 4 indexed citations

13.

Scheurlen, H, et al.. (1979). Clinical Trials in ‘Early’ Breast Cancer. 17 indexed citations

14.

Scheurlen, H, et al.. (1977). [A controlled clinical study of early mobilisation of patients with myocardial infarction (author's transl)].. PubMed. 72(11). 465–70. 2 indexed citations

15.

Immich, H, et al.. (1975). Können Neuroleptika Krebs verhüten?. Pharmacopsychiatry. 8(6). 357–365. 3 indexed citations

16.

Scheurlen, H, et al.. (1972). [Radiotherapy of the inoperable bronchial carcinoma in combination with endoxan therapy].. PubMed. 143(2). 154–8. 4 indexed citations

17.

Georgi, M., et al.. (1968). [Angiography in pelvic tumors].. PubMed. 8(6). 185–90. 3 indexed citations

18.

Becker, J, et al.. (1967). [Indication establishment and dosimetry in endolymphatic therapy with I-131 lipiodol].. PubMed. 133(4). 481–98. 1 indexed citations

19.

Dannenberg, Heinz, et al.. (1956). Darstellung von Azinen ungesättigter 3‐Keto‐steroide. Justus Liebig s Annalen der Chemie. 600(1). 68–80. 4 indexed citations

20.

Dannenberg, Heinz, et al.. (1956). Notiz zur Dehydrierung von Cholesterin mit Chloranil. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 303(Jahresband). 282–285. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact